Cholera - Annual Epidemiological Report for 2016
Cholera is a rare travel-associated disease in the EU/EEA. In 2016, six EU/EEA countries reported 23 laboratory-confirmed cases of cholera, which was in the range of previous years. All cases with known travel history were infected outside of Europe.
Annual Epidemiological Report 2009 [2007 data]
This edition of the Annual Report gives special attention to vaccine-preventable diseases and immunisation programmesin the European Union (EU) and European Economic Area (EEA) countries. This edition was revised January and June 2010 and has authority over the print edition.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Sexually transmitted infections
- Vaccine preventable diseases
- Vector-borne disease
Yersiniosis - Annual Epidemiological Report for 2016
In 2016, 28 countries reported 6 918 confirmed yersiniosis cases in the EU/EEA.
Anthrax - Annual Epidemiological Report for 2016
Anthrax continues to be a rare disease in humans in Europe, with only a few cases reported every year. In 2016, two EU/EEA countries reported six laboratory-confirmed anthrax cases: Romania (5) and Spain (1). The remaining 28 reporting countries notified no cases.
Congenital toxoplasmosis – Annual Epidemiological Report for 2016
In 2016, 242 confirmed cases of congenital toxoplasmosis were reported in the EU/EEA, with France accounting for 81% of all confirmed cases due to the active screening of pregnant women. The notification rate was 6.7 cases per 100 000 live births. No seasonal pattern was observed for the disease.
Tularaemia - Annual Epidemiological Report for 2016
For 2016, 1 148 cases of tularaemia were reported in the EU/EEA, 1 096 (95%) of which were confirmed.
Tularaemia Annual Epidemiological Report for 2018
For 2018, 18 countries in the EU/EEA reported 441 cases of tularaemia, 358 (81%) of which were confirmed. The EU/EEA notification rate for 2018 was 0.07 cases per 100 000 population. The male-to-female ratio was 1.7:1. As in previous years, the notification rate among males was higher in most age groups except for the age groups between 5 and 24 years. Notification rates increased with age and peaked at 45–64 years.